Selection of New Probiotics for Endometrial Health

Microbiota is a crucial player in gynecologic health, in which bacteria can shift to a dysbiotic state triggering a pathogenic process. Based on an ecological understanding of the problem, the aim of this study is to select a potential probiotic strain to improve female reproductive tract based on i...

Full description

Bibliographic Details
Main Authors: Empar Chenoll, Inmaculada Moreno, María Sánchez, Iolanda Garcia-Grau, Ángela Silva, Marta González-Monfort, Salvador Genovés, Felipe Vilella, Cristina Seco-Durban, Carlos Simón, Daniel Ramón
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcimb.2019.00114/full
id doaj-adebfa32593b460dbe2f6edd9f7e0daa
record_format Article
spelling doaj-adebfa32593b460dbe2f6edd9f7e0daa2020-11-25T01:58:50ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882019-04-01910.3389/fcimb.2019.00114448143Selection of New Probiotics for Endometrial HealthEmpar Chenoll0Inmaculada Moreno1Inmaculada Moreno2María Sánchez3Iolanda Garcia-Grau4Iolanda Garcia-Grau5Ángela Silva6Marta González-Monfort7Salvador Genovés8Felipe Vilella9Cristina Seco-Durban10Carlos Simón11Carlos Simón12Carlos Simón13Carlos Simón14Daniel Ramón15Biopolis SL/Archer Daniels Midland, R&D Department, Valencia, SpainIgenomix Foundation, Instituto de Investigación Sanitaria Hospital Clínico (INCLIVA), Valencia, SpainIgenomix SL, Research Department, Paterna, SpainBiopolis SL/Archer Daniels Midland, R&D Department, Valencia, SpainIgenomix Foundation, Instituto de Investigación Sanitaria Hospital Clínico (INCLIVA), Valencia, SpainDepartment of Obstetrics and Gynecology, University of Valencia, Valencia, SpainBiopolis SL/Archer Daniels Midland, R&D Department, Valencia, SpainIgenomix SL, Research Department, Paterna, SpainBiopolis SL/Archer Daniels Midland, R&D Department, Valencia, SpainIgenomix Foundation, Instituto de Investigación Sanitaria Hospital Clínico (INCLIVA), Valencia, SpainFerring Pharmaceuticals, Madrid, SpainIgenomix Foundation, Instituto de Investigación Sanitaria Hospital Clínico (INCLIVA), Valencia, SpainIgenomix SL, Research Department, Paterna, SpainDepartment of Obstetrics and Gynecology, University of Valencia, Valencia, SpainDepartment of Obstetrics and Gynecology, School of Medicine, Stanford University, Palo Alto, CA, United StatesBiopolis SL/Archer Daniels Midland, R&D Department, Valencia, SpainMicrobiota is a crucial player in gynecologic health, in which bacteria can shift to a dysbiotic state triggering a pathogenic process. Based on an ecological understanding of the problem, the aim of this study is to select a potential probiotic strain to improve female reproductive tract based on its capacity to initially lower pH and to promote the reduction of pathogenic bacteria. Based on this rationale, strain Lactobacillus rhamnosus BPL005 was initially selected for its capacity to reduce in vitro pH levels and produce organic acids. Subsequently, strain L. rhamnosus BPL005 (CECT 8800) was demonstrated to have a protective role on endometrial infections in an in vitro model of bacterial colonization of primary endometrial epithelial cells with Atopobium vaginae, Gardnerella vaginalis, Propionibacterium acnes, and Streptococcus agalactiae. In this model, BPL005 when co-cultured with those pathogens was shown to lower pH and to produce organic acids, being lactic acid the most relevant. The co-cultivation of strain L. rhamnosus BPL005 with tested reference pathogens produced a significant reduction in P. acnes and St. agalactiae levels and a non-significant reduction in A. vaginae and G. vaginalis. The colonization of L. rhamnosus BPL005 in the culture decreased IL-6, IL-8, and MCP-1, heightened in the presence of pathogens, and increased IL-1RA and IL-1 beta. Finally, safety was evaluated showing no signs of cytotoxicity, irritation in vaginal tests, or allergic contact dermatitis potential through the Local Lymph Node Assay. Overall, these results show the potential of L. rhamnosus BPL005 strain as a probiotic in gynecological health.https://www.frontiersin.org/article/10.3389/fcimb.2019.00114/fullL. rhamnosus BPL005 (CECT 8800)endometrial healthgynecological pathogensprobioticpathogen inhibition
collection DOAJ
language English
format Article
sources DOAJ
author Empar Chenoll
Inmaculada Moreno
Inmaculada Moreno
María Sánchez
Iolanda Garcia-Grau
Iolanda Garcia-Grau
Ángela Silva
Marta González-Monfort
Salvador Genovés
Felipe Vilella
Cristina Seco-Durban
Carlos Simón
Carlos Simón
Carlos Simón
Carlos Simón
Daniel Ramón
spellingShingle Empar Chenoll
Inmaculada Moreno
Inmaculada Moreno
María Sánchez
Iolanda Garcia-Grau
Iolanda Garcia-Grau
Ángela Silva
Marta González-Monfort
Salvador Genovés
Felipe Vilella
Cristina Seco-Durban
Carlos Simón
Carlos Simón
Carlos Simón
Carlos Simón
Daniel Ramón
Selection of New Probiotics for Endometrial Health
Frontiers in Cellular and Infection Microbiology
L. rhamnosus BPL005 (CECT 8800)
endometrial health
gynecological pathogens
probiotic
pathogen inhibition
author_facet Empar Chenoll
Inmaculada Moreno
Inmaculada Moreno
María Sánchez
Iolanda Garcia-Grau
Iolanda Garcia-Grau
Ángela Silva
Marta González-Monfort
Salvador Genovés
Felipe Vilella
Cristina Seco-Durban
Carlos Simón
Carlos Simón
Carlos Simón
Carlos Simón
Daniel Ramón
author_sort Empar Chenoll
title Selection of New Probiotics for Endometrial Health
title_short Selection of New Probiotics for Endometrial Health
title_full Selection of New Probiotics for Endometrial Health
title_fullStr Selection of New Probiotics for Endometrial Health
title_full_unstemmed Selection of New Probiotics for Endometrial Health
title_sort selection of new probiotics for endometrial health
publisher Frontiers Media S.A.
series Frontiers in Cellular and Infection Microbiology
issn 2235-2988
publishDate 2019-04-01
description Microbiota is a crucial player in gynecologic health, in which bacteria can shift to a dysbiotic state triggering a pathogenic process. Based on an ecological understanding of the problem, the aim of this study is to select a potential probiotic strain to improve female reproductive tract based on its capacity to initially lower pH and to promote the reduction of pathogenic bacteria. Based on this rationale, strain Lactobacillus rhamnosus BPL005 was initially selected for its capacity to reduce in vitro pH levels and produce organic acids. Subsequently, strain L. rhamnosus BPL005 (CECT 8800) was demonstrated to have a protective role on endometrial infections in an in vitro model of bacterial colonization of primary endometrial epithelial cells with Atopobium vaginae, Gardnerella vaginalis, Propionibacterium acnes, and Streptococcus agalactiae. In this model, BPL005 when co-cultured with those pathogens was shown to lower pH and to produce organic acids, being lactic acid the most relevant. The co-cultivation of strain L. rhamnosus BPL005 with tested reference pathogens produced a significant reduction in P. acnes and St. agalactiae levels and a non-significant reduction in A. vaginae and G. vaginalis. The colonization of L. rhamnosus BPL005 in the culture decreased IL-6, IL-8, and MCP-1, heightened in the presence of pathogens, and increased IL-1RA and IL-1 beta. Finally, safety was evaluated showing no signs of cytotoxicity, irritation in vaginal tests, or allergic contact dermatitis potential through the Local Lymph Node Assay. Overall, these results show the potential of L. rhamnosus BPL005 strain as a probiotic in gynecological health.
topic L. rhamnosus BPL005 (CECT 8800)
endometrial health
gynecological pathogens
probiotic
pathogen inhibition
url https://www.frontiersin.org/article/10.3389/fcimb.2019.00114/full
work_keys_str_mv AT emparchenoll selectionofnewprobioticsforendometrialhealth
AT inmaculadamoreno selectionofnewprobioticsforendometrialhealth
AT inmaculadamoreno selectionofnewprobioticsforendometrialhealth
AT mariasanchez selectionofnewprobioticsforendometrialhealth
AT iolandagarciagrau selectionofnewprobioticsforendometrialhealth
AT iolandagarciagrau selectionofnewprobioticsforendometrialhealth
AT angelasilva selectionofnewprobioticsforendometrialhealth
AT martagonzalezmonfort selectionofnewprobioticsforendometrialhealth
AT salvadorgenoves selectionofnewprobioticsforendometrialhealth
AT felipevilella selectionofnewprobioticsforendometrialhealth
AT cristinasecodurban selectionofnewprobioticsforendometrialhealth
AT carlossimon selectionofnewprobioticsforendometrialhealth
AT carlossimon selectionofnewprobioticsforendometrialhealth
AT carlossimon selectionofnewprobioticsforendometrialhealth
AT carlossimon selectionofnewprobioticsforendometrialhealth
AT danielramon selectionofnewprobioticsforendometrialhealth
_version_ 1724967805157113856